Medicine
Sojourn 1 mL/mL inhalation solution
Sojourn 1 mL/mL inhalation solution is a prescription medicine containing Sevoflurane for inhalation use, marketed by Piramal Critical Care, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Storage as on the product label
Key facts
- Active ingredient (INN)
- Sevoflurane
- Brand
- Sojourn
- Strength
- 1 mL/mL
- Dosage form
- Inhalation solution
- Route
- Inhalation
- Packs
- 250 mL
- Marketing authorisation holder
- Piramal Critical Care
- Manufacturer
- Piramal Critical CareIndia
- Origin register
- US FDA, United States
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N01AB08 Sevoflurane
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 13 April 2010
- Identifiers
- RxCUI 200243, 997625DailyMed set ID fedfd1db-7e32-44b2-89e9-7bb00ee6810dNDC 66794-012Application ANDA077867
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 250 mL in 1 bottle, glass | 66794-012-25 | Piramal Critical CareIndia | 13 April 2010 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 7 June 1995 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Sevoflurane
Clinical summary
Sevoflurane is a general anesthetic indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery. It is available as inhalation solution. MedsAcross supplies Sevoflurane for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about SevofluraneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Ultane prescribing information (AbbVie) · U.S. National Library of Medicine, DailyMed
Need Sojourn 1 mL/mL inhalation solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.